ロード中...
Increased Bone Mineral Density with Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients with Primary Osteoporosis: Three-Year Analysis of the MOVER Study
The relationship between gains in bone mineral density (BMD) in the hip and the incidence of vertebral fractures in the MOVER study was examined. Japanese patients from the ibandronate and risedronate treatment groups whose hip BMD had increased during the 3-year treatment period were classified int...
保存先:
| 出版年: | Calcif Tissue Int |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4239781/ https://ncbi.nlm.nih.gov/pubmed/25377907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-014-9927-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|